Skip to main content
Watch Insiders
ZNTLHealthcare

Zentalis Pharmaceuticals Inc (ZNTL) Insider Trading

In the last 90 days, 3 Zentalis Pharmaceuticals Inc (ZNTL) insiders reported 3 open-market purchases totaling $45,517,500 and no sales. The most recent open-market purchase was reported on Aug 14, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$45,517,500
Corporate buyers
3
Latest transaction
Aug 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 14, 2026Walters GroupCorporate insiderOpen Market Purchase4,335,000$3.50$15,172,500
Aug 14, 2026William Thurman WaltersCorporate insiderOpen Market Purchase4,335,000$3.50$15,172,500
Aug 14, 2026Susan Berkley WaltersCorporate insiderOpen Market Purchase4,335,000$3.50$15,172,500

Common questions

ZNTL insider trading FAQ

Are ZNTL insiders buying or selling?
Over the last 90 days, ZNTL insiders were net buyers, reporting $45,517,500 of open-market purchases and $0.00 of sales.
When was the last ZNTL insider purchase?
The most recent open-market purchase of Zentalis Pharmaceuticals Inc stock by an insider was reported on Aug 14, 2026, one of 3 purchases in the last 90 days.
Where does ZNTL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Zentalis Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.